83
Participants
Start Date
August 31, 2011
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Tofacitinib
Subjects who previously took 15 mg BID or 30 mg BID
Tofacitinib
Subjects who previously took 15 mg BID for 3 months then 10 mg BID, or 15 mg BID for 6 months then 10 mg BID
Pfizer Investigational Site, Anderlecht
Pfizer Investigational Site, Camperdown
Pfizer Investigational Site, Westmead
Pfizer Investigational Site, Parkville
Pfizer Investigational Site, Clayton
Pfizer Investigational Site, Adelaide
Pfizer Investigational Site, New York
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Valhalla
Pfizer Investigational Site, Praha 4 - Krc
Pfizer Investigational Site, Hamburg
Pfizer Investigational Site, Richmond
Pfizer Investigational Site, Toulouse
Pfizer Investigational Site, Tampa
Pfizer Investigational Site, Nantes
Pfizer Investigational Site, Ann Arbor
Pfizer Investigational Site, Detroit
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Fort Worth
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, San Francisco
Pfizer Investigational Site, San Francisco
Pfizer Investigational Site, Palo Alto
Pfizer Investigational Site, Stanford
Pfizer Investigational Site, Boston
Pfizer Investigational Site, Springfiled
Pfizer Investigational Site, Livingston
Pfizer Investigational Site, Chapel Hill
Pfizer Investigational Site, Porto Alegre
Pfizer Investigational Site, São Paulo
Pfizer Investigational Site, Edmonton
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Rotterdam
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, L'Hospitalet de Llobregat
Lead Sponsor
Pfizer
INDUSTRY